{"id":70301,"date":"2025-12-22T14:03:08","date_gmt":"2025-12-22T14:03:08","guid":{"rendered":"https:\/\/www.europesays.com\/ee\/70301\/"},"modified":"2025-12-22T14:03:08","modified_gmt":"2025-12-22T14:03:08","slug":"kihutav-novo-nordiski-suurim-konkurent-teeb-kadedaks","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/ee\/70301\/","title":{"rendered":"Kihutav Novo Nordiski suurim konkurent teeb kadedaks"},"content":{"rendered":"<p>Hiljuti Investeerimisklubis oma kaasteelistega muljeid vahetades, tuli arutelu alla \u00fcks ravimitegelane, keda ma varem v\u00e4ga l\u00e4hemalt vaadanud ei olegi. Kuigi minu portfellist leiab s\u00fcgavalt punasesse kukkunud Taani ravimitootja Novo Nordiski, siis peatsetele punastele p\u00fchadele kohaselt otsustasin uurida konkurentsi pakkuva Eli Lilly tausta.<\/p>\n","protected":false},"excerpt":{"rendered":"Hiljuti Investeerimisklubis oma kaasteelistega muljeid vahetades, tuli arutelu alla \u00fcks ravimitegelane, keda ma varem v\u00e4ga l\u00e4hemalt vaadanud ei&hellip;\n","protected":false},"author":2,"featured_media":70302,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[14],"tags":[131,130,37,33,35,34,36],"class_list":{"0":"post-70301","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-ari","8":"tag-ari","9":"tag-business","10":"tag-ee","11":"tag-eesti","12":"tag-eesti-keel","13":"tag-estonia","14":"tag-estonian"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@ee\/115763596914557631","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ee\/wp-json\/wp\/v2\/posts\/70301","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ee\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ee\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ee\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ee\/wp-json\/wp\/v2\/comments?post=70301"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ee\/wp-json\/wp\/v2\/posts\/70301\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ee\/wp-json\/wp\/v2\/media\/70302"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ee\/wp-json\/wp\/v2\/media?parent=70301"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ee\/wp-json\/wp\/v2\/categories?post=70301"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ee\/wp-json\/wp\/v2\/tags?post=70301"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}